<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2012</study_start_year><condition>Colorectal cancer metastatic</condition><condition>Metastatisk colorectal cancer med metastaser isoleret til leveren.</condition><condition>Metastatic colorectal cancer with metastasis confined to the liver</condition><disease>Metastatic Colorectal Cancer With Metastasis Confined To The Liver</disease><disease>Colorectal Cancer Metastatic</disease><disease>Metastatisk Colorectal Cancer Med Metastaser Isoleret Til Leveren.</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2530694</full_dataset_link><location>Denmark</location><study_start_month>7</study_start_month><keyword>Irinotecan</keyword><repository>ECRIN MDR</repository><study_status>Terminated</study_status></additional><is_claimable>false</is_claimable><name>Regional Chemotherapy with Intrahepatic Irinotecan Beads for patients with Livermetastatic Colorectal Cancer.</name><description>Primary objectives: To investigate the effect of drug eluting bead with irinotecan-trans arteriel chemoembolizatin, administered in combination with FOLFOX and bevacizumab, followed by standard treatment with FLIRI and bevacizumab in patients with liver-only metastatic CRC .
Primary endpoints: Frequency of surgical resection and / or RFA treatment.</description><dates><creation>2012-07-15</creation></dates><accession>2530694</accession><cross_references><EU Clinical Trials Register>2012-000987-11</EU Clinical Trials Register></cross_references></HashMap>